3D·

Bye Novo

$NOVO B (-1,97%) has left my portfolio again. It's a bit too uncertain for me at the moment, so I preferred to secure my small profit. One or two days earlier would have been better, of course, but what the heck. I could possibly imagine re-entering the market if they drop again after the figures. Otherwise the money will go into an ETF as invest and forget money.

29.01
Novo Nordisk logo
Vendido x125 em € 49,79
€ 6.223,75
19,68%
16
8 Comentários

imagem de perfil
absolute nonsense, there is nothing uncertain, they are in a huge future market in an oligopoly... don't understand where you see uncertainties with an approved oral pill and a functioning product
8
Mostrar resposta
imagem de perfil
very good min young, away with the chip shop, means only Ärger❤️
Ver todas as 2 restantes respostas
imagem de perfil
Why buying the company if it's to abandon it right when good news are aligning ?
@Jo_Wolf what good news in particular?
imagem de perfil
@Solitair TrumpRX go live tomorrow with Novo's GLP drugs in focus.
Prescription numbers in first week of Oral Wegovy are good.
Legal battles between Novo and generic manufacturers, while still ongoing, have a huge change of been won as per US government statements favoring Novo.
US - Novo Deal while short term pricing hurts, the customer base expansion long term makes it worth it.
Deal with Amazon Pharmacy, Sesame Healthcare, GoodRX, LifeMD...
3
Participar na conversa